Pyrazole carboxamide derivatives, pharmaceutical...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S279000, C514S336000, C514S337000, C514S338000, C514S403000, C514S406000

Reexamination Certificate

active

08030323

ABSTRACT:
A compound of formula (I) or pharmaceutically acceptable salts and/or solvates or hydrates thereof. A process for preparing the compound, a pharmaceutical composition comprising the compound and an application for resisting cannabinoid CB1 receptor are provided.

REFERENCES:
patent: 5462960 (1995-10-01), Barth et al.
patent: 6432984 (2002-08-01), Barth et al.
patent: 6509367 (2003-01-01), Martin et al.
patent: 2 136 893 (2002-06-01), None
patent: 03/088968 (2003-10-01), None
European Patent Office, Extended European Search Report for 0770216.2-2117/1975168 PCT/CN2007/000084, Jul. 22, 2010, Munich, Germany.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazole carboxamide derivatives, pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole carboxamide derivatives, pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole carboxamide derivatives, pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4290906

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.